-
BioMed Central will host the second biennial Metabolism, Diet and Disease: Metabolism & Cancer conference on 28thto 30thMay 2014 at L’Enfant Plaza Hotel in Washington DC, USA.
Visit the new website here
-
BioMed Central held its first conference on Metabolism, Diet and Disease in Washington DC from 29-31 May 2012.
The aim of the conference was to show how basic research on the biochemistry, cell biology and genetics of metabolism could address the major health problems of cancer, obesity, diabetes and insulin resistance, and explain ageing and longevity.
Contributions from nutritionists and epidemiologists were included, with a panel discussion focused on the connection between cancer and obesity and what we can do about it – both by understanding the link and by tackling obesity with scientifically informed strategies.
Conference-related publications:
· A video of the panel discussion from the conference can be viewed by clicking here.
· Thematic article series - Metabolism, diet and disease
· Cross-journal article collection - Nutrition and metabolism in health and disease
· Meeting abstracts
-
|

|
Richard Bergman, Cedars-Sinai Medical Center, USA
|

|
Michael S. Brown, University of Texas Southwestern Medical Center, USA
|
|

|
Lewis Cantley, Harvard Medical School and Beth Israel Deaconess Hospital, USA
|

|
Joseph L. Goldstein, University of Texas Southwestern Medical Center, USA
|
|

|
Leonard Guarente, Massachusetts Institute of Technology, USA
|

|
Stephen Hursting, University of Texas and MD Anderson Cancer Center, USA
|
|

|
Michael Pollak, McGill University and Jewish General Hospital, Canada
|

|
Craig Thompson, Memorial Sloan-Kettering Cancer Center, USA
|
-
|

|
Rafael de Cabo, National Institute on Aging, NIH, USA
|

|
Christine Ferguson, The George Washington University, USA
|
|

|
Jeffrey Friedman, The Rockefeller University, USA
|
 |
Marcia Haigis, Harvard Medical School, USA |
|

|
Grahame Hardie, University of Dundee, UK
|

|
Rudolf Kaaks, German Cancer Research Center, Germany
|
|

|
Barbara Kahn, Harvard Medical School and Beth Israel Deaconess Hospital, USA
|
 |
Mitchell Lazar, University of Pennsylvania, USA
|
 |
David Mangelsdorf, University of Texas Southwestern Medical Center, USA |

|
Raul Mostoslavsky,
Massachusetts General Hospital and Harvard Medical School, USA |
 |
Linda Nebeling, National Cancer Institute, USA |
 |
Christopher Newgard, Duke University Medical Center, USA |
|

|
Gregory Petsko, Weill Cornell Medical College and Brandeis University, USA
|

|
David Sabatini, Massachusetts Institute of Technology, USA
|
|

|
Bruce Spiegelman, Harvard Medical School and Dana-Farber Cancer Institute, USA
|

|
Luc Tappy, University of Lausanne, Switzerland
|
|

|
Gary Taubes, Independent Investigator, University of California Berkeley, USA
|

|
Jeff Volek, University of Connecticut, USA
|
 |
Eric Westman, Duke University Medical Center, USA |
|
|
-
BioMed Central (http://www.biomedcentral.com) is an STM (Science, Technology and Medicine) publisher that has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
|
|